Skip to main content

Fidelity D & D Bancorp, Inc. Reports Third Quarter 2025 Financial Results

DUNMORE, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank, announced its unaudited, consolidated financial results for the three- and nine-month periods ended September 30, 2025. Unaudited Financial Information Net income for the quarter ended September 30, 2025 was $7.3 million, or $1.27 per diluted share, compared to $5.0 million, or $0.86 per diluted share, for the quarter ended September 30, 2024.  The $2.3 million, or 48%, increase in net income resulted primarily from a $3.0 million increase in net interest income coupled with a $0.5 million decrease in provision for credit losses on loans and unfunded commitments. This was partially offset by a $0.8 million increase in non-interest expense and a $0.4 million increase...

Continue reading

Mullen Group Ltd. Acquisitions Continue to Drive Growth in the Third Quarter of 2025

OKOTOKS, Alberta, Oct. 22, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group“, “We“, “Our” and/or the “Corporation“), one of Canada’s largest logistics providers today reported its financial and operating results for the period ended September 30, 2025, with comparisons to the same period last year.   Full details of our results may be found within our Third Quarter Interim Report, which is available on the Corporation’s issuer profile on SEDAR+ at www.sedarplus.ca or on our website at www.mullen-group.com. “Our acquisition strategy continued to drive top line growth in the quarter. This is especially satisfying given the current state of the Canadian economy, which continues to struggle with a number of trade and tariff related issues, along with...

Continue reading

Elanders AB: Quarterly Report January – September 2025

January – September 2025Net sales amounted to MSEK 9,148 (10,369), which corresponded to an organic net sales reduction of three percent compared to the same period last year, excluding acquisitions and discontinued operations, and using unchanged exchange rates. Adjusted EBITA amounted to MSEK 510 (632), which equaled an adjusted EBITA margin of 5.6 (6.1) percent. Operating profit was impacted by one-off items of MSEK -185 (66), which mainly referred to structural measures to meet a weaker market and over time improve the Group’s margins. The structural measures are expected to result in annual cost savings of around MSEK 232, of which around MSEK 99 in 2025. Adjusted result after tax amounted to MSEK 38 (117), corresponding to SEK 0.98 (3.20) per share. Operating cash flow adjusted for purchase prices for acquisitions amounted to MSEK...

Continue reading

Correction: Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025

Correction to company announcement in English: The English company announcement regarding the report for the first three quarters of 2025 incorrectly included figures from the half year. This announcement has now been updated with the correct figures of the first three quarters of 2025. The attached reports are unchanged.Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeOther stakeholders 22 October 2025 Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025 The bank’s board of directors and general management today approved the report for the first three quarters of 2025. The bank delivers core earnings of DKK 2,321 million and net profit of DKK 1,753 million in the first three quarters of the year. The net profit is equivalent to a 21% p.a. return on equity.Core earnings(DKK million) Q1-Q3 2025 Q1-Q3 2024 2024 2023 2022 2021Total...

Continue reading

Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeOther stakeholders 22 October 2025 Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025 The bank’s board of directors and general management today approved the report for the first three quarters of 2025. The bank delivers core earnings of DKK 2,321 million and net profit of DKK 1,753 million in the first three quarters of the year. The net profit is equivalent to a 21% p.a. return on equity.Core earnings(DKK million) Q1-Q3 2025 Q1-Q3 2024 2024 2023 2022 2021Total core income 2,090 3,067 4,068 3,828 2,862 2,433Total expenses and depreciation 534 761 1,044 963 891 817Core earnings before impairment charges for loans 1,556 2,306 3,024 2,865 1,971 1,616Impairment charges for loans etc. +24 +2 +3 -1 -2 -68Core earnings 1,580 2,308 3,027 2,864 1,969 1,548Result...

Continue reading

Heineken N.V. reports on 2025 third quarter trading

  Amsterdam, 22 October 2025 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announces Staying the course while navigating a challenging quarterKey Quarterly Highlights  Revenue €8,712 million for the quarter, €25,636 million year to dateNet revenue (beia) organically down 0.3% for the quarter, up 1.3% year to dateBeer volume organically down 4.3% for the quarter, down 2.3% year to datePremium beer volume organically down 2.2% for the quarter, up 0.4% year to dateHeineken® volume down 0.6% for the quarter, up 2.7% year to date2025 organic operating profit (beia) growth anticipated to be towards the lower end of the 4% to 8% guidanceCEO Statement  Dolf van den Brink, Chairman of the Executive Board / CEO, commented: “Macroeconomic volatility persisted as anticipated and became more pronounced in...

Continue reading

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioSolutions was attributable to sustained growth in sales to agriculture. In BioMaterials, higher sales prices were more than offset by lower sales volume. Fine chemical intermediates delivered a strong result. Net currency effects were positive across all areas. Profit before tax was NOK 247 million (NOK 326 million)....

Continue reading

Coop Pank unaudited financial results for Q3 2025

By the end of the Q3 2025, Coop Pank had 222,000 customers, increased by 4,000 customers in the quarter (+2%) and by 20,000 in the year (+10%). The bank had 105,400 active customers, increased by 1,800 (+2%) in the quarter and by 10,000 (+10%) in the year. In Q3 2025, volume of deposits in Coop Pank increased by 105 million euros (+6%), reaching total of 1.91 billion euros. Deposits from private customers increased by 9 million euros: demand deposits remained at the same level compared to the previous quarter and term deposits increased by 9 million euros. Deposits from domestic business customers increased by 24 million euros: demand deposits increased by 44 million euro and term deposits decreased by 20 million euros. Deposits from international deposit platform increased by 71 million euros and other financing increased by 40 million...

Continue reading

Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance

Year-to-date total sales growth of 12.1% at CER1, or 9.6% as reported, driven by all three therapeutic areas and including strong performance from Iqirvo®, Bylvay® and Somatuline® Further upgrade of full-year 2025 financial guidance based on slower than anticipated erosion of Somatuline® and accelerated sales growth of the rest of the portfolio: total sales growth of around 10.0%2 at CER (prior guidance greater than 7.0%); core operating margin of around 35.0% of total sales (prior guidance greater than 32.0%) Announcement today of the proposed acquisition of ImCheck Therapeutics bringing a first-in-class Phase II asset, expanding pipeline in oncologyPARIS, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the year to date and the third...

Continue reading

Teck Reports Unaudited Third Quarter Results for 2025

Merger of equals to create new global critical minerals champion and unlock substantial value VANCOUVER, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (Teck) today announced its unaudited third quarter results for 2025. “The merger of equals between Teck and Anglo American announced this quarter is a unique opportunity to create a global leader in critical minerals and a top five copper producer,” said Jonathan Price, President and CEO. “The combination will unlock significant value for shareholders through integration of Quebrada Blanca and Collahuasi and meaningful corporate synergies, offering a compelling high-quality, copper-focused investment opportunity. In addition, we completed a Comprehensive Operational Review to ensure our business plans...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.